August 31, 2016 5:54 PM ET


Company Overview of Five Prime Therapeutics, Inc.

Key Executives for Five Prime Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Lewis T. Williams M.D., Ph.D.34 RelationshipsFounder, Chairman, Chief Executive Officer and President67
Marc L. Belsky No RelationshipsChief Financial Officer and Senior Vice President61
Kevin P. Baker Ph.D.No RelationshipsSenior Vice President of Development Sciences--
Aron Marc Knickerbocker 19 RelationshipsChief Business Officer, Executive Vice President and Director47
Francis W. Sarena No RelationshipsExecutive Vice President, General Counsel and Secretary45
View More Key Executives

Five Prime Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Lewis T. Williams M.D., Ph.D. 34 RelationshipsFive Prime Therapeutics, Inc.67
Aron Marc Knickerbocker 19 RelationshipsFive Prime Therapeutics, Inc.47
Franklin M. Berger CFA, BA, MA, MBA 107 RelationshipsFive Prime Therapeutics, Inc.66
Peder K. Jensen M.D. 44 RelationshipsFive Prime Therapeutics, Inc.61
Sheila Gujrathi M.D. 19 RelationshipsFive Prime Therapeutics, Inc.46
View All Board Members

Five Prime Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CFA, BA, MA, MBAFranklin M. Berger107 Relationships2 Executives
Compensation Committee M.D.Sheila Gujrathi19 Relationships3 Executives
Nominating Committee M.D.Peder K. Jensen44 Relationships2 Executives
Corporate Governance Committee M.D.Peder K. Jensen44 Relationships2 Executives
Management/Organization Development Committee M.D.Sheila Gujrathi19 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$525.0K
Total Value of Options
Compensation as of Fiscal Year
Five Prime Therapeutics, Inc. CEO Compensation
Industry Average


Bionomics Ltd. Announces Board Changes
August 30, 2016 11:15 PM ET
Cellceutix Further Expands its Senior Management Team
August 30, 2016 6:07 PM ET
Tizona Therapeutics, Inc. Appoints George Golumbeski to Board of Directors
August 30, 2016 1:00 PM ET
Nutra Pharma Announces Addition of Kenneth Dowd to its Advisory Board
August 30, 2016 12:30 PM ET
Pliant Therapeutics Appoints Suzanne Bruhn, Ph.D., to its Board of Directors
August 30, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Five Prime Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at